英文名稱(chēng) | Theralizumab | TGN1412 | TAB-08 | TABO8 |
---|---|
中文名稱(chēng) | 西拉利珠單抗 |
CAS號(hào) | 906068-56-2 |
儲(chǔ)存條件 | store at -20°C | Shipping with blue ice. |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專(zhuān)享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5days | ¥3236.00 | 登錄后可見(jiàn) | |
5 mg | 3-5days | ¥8480.00 | 登錄后可見(jiàn) |
英文名稱(chēng) | Theralizumab | TGN1412 | TAB-08 | TABO8 |
---|---|
中文名稱(chēng) | 西拉利珠單抗 |
CAS號(hào) | 906068-56-2 |
儲(chǔ)存條件 | store at -20°C | Shipping with blue ice. |
Theralizumab (TGN1412) is a humanized lgG4 superagonistic anti-CD28 monoclonal antibody that directly stimulates T cells. Theralizumab can cause cytokine release syndrome (CRS). Theralizumab can be used for the research of rheumatoid arthritis.